Dr Lee Dong-ki, founder and CEO
Dr Lee Dong-ki, founder and CEO

OliX Pharmaceuticals develops ribonucleotide technologies for untreatable diseases

  • OliX Pharmaceuticals is a first-mover biotechnology company with a growing number of proprietary nucleotide solutions at various stages of clinical development

Dr Lee Dong-ki, founder and CEO
Dr Lee Dong-ki, founder and CEO
READ FULL ARTICLE